Immunoglobulin‐like transcript subunit 4 (ILT4), an inhibitory receptor of the immunoglobulin superfamily [26], plays a regulatory role in EGFR‐mutated NSCLC tumor cells by modulating the ERK/Akt signaling pathway. This evidence concerns the gene LILRB2 and neoplasm.